Breaking Glucose Transporter 1/Pyruvate Kinase M2 Glycolytic Loop Is Required for Cantharidin Inhibition of Metastasis in Highly Metastatic Breast Cancer

Yanhong Pan(Nanjing University of Chinese Medicine), Yin Lu(Nanjing University of Chinese Medicine)

Frontiers in Pharmacology

May 24, 2019

10.3389/fphar.2019.00590

Cited by 43

Related Papers

Antimetastatic Therapies of the Polysulfide Diallyl Trisulfide against Triple-Negative Breast Cancer (TNBC) via Suppressing MMP2/9 by Blocking NF-κB and ERK/MAPK Signaling Pathways

|PLoS ONE|2015|103

Tianfoshen oral liquid: a CFDA approved clinical traditional Chinese medicine, normalizes major cellular pathways disordered during colorectal carcinogenesis

|Oncotarget|2017|71

Critical role of mTOR in regulating aerobic glycolysis in carcinogenesis (Review)

|International Journal of Oncology|2020|67

Xanthatin Induces Cell Cycle Arrest at G2/M Checkpoint and Apoptosis via Disrupting NF-κB Pathway in A549 Non-Small-Cell Lung Cancer Cells

|Molecules|2012|60

Paeonol inhibits <scp>B</scp>16<scp>F</scp>10 melanoma metastasis <i>In vitro</i> and <i>In Vivo</i> via disrupting proinflammatory cytokines‐mediated <scp>NF</scp>‐κ<scp>B</scp> and <scp>STAT</scp>3 pathways

|IUBMB Life|2015|59